Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 1956 (LINC01956) is a non-coding RNA transcript located in an intergenic region, meaning it does not overlap with protein-coding genes[1][3]. LINC01956 belongs to the lincRNA family, which is characterized by transcripts longer than 200 nucleotides that play roles in chromatin architecture, transcriptional regulation, and gene expression[3][5]. LincRNAs, including LINC01956, are generally involved in fine-tuning the expression of nearby or distant genes through sequence-dependent or sequence-independent mechanisms, often exhibiting tissue-specific expression[3][5]. The specific biological and disease relevance of LINC01956 has not been systematically studied, and it is not currently classified as a therapeutic target, biomarker, or drug-interacting molecule[1][3][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1956 (LINC01956).